Curis (CRIS) – Mergers and Acquisitions
-
Curis (CRIS) Sells Portion of Erivedge Royalties for up to $135.7 million
-
Curis (CRIS) Announces FDA Fast Track Designation for Fimepinostat Development in Patients with R/R Diffuse Large B-Cell Lymphoma
Back to CRIS Stock Lookup